Phibro Animal Health Corporatio (PAHC) Revenue & Earnings 2020-2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Revenue & Profit
Revenue, EBITDA, operating income, net income, EPS, and shares across quarters
TTM Revenue
$1.52B
17.1%
Q. Revenue
$396.75M
TTM EBITDA
$245.91M
57.6%
TTM Op. Income
$194.40M
76.0%
Q. Op. Income
$48.16M
TTM Net Income
$99.72M
106.6%
Q. Net Income
$21.71M
EPS
$0.535
Shares Out.
$40.56M
0.1%
$1.52B in TTM revenue grew 17.1% YoY, reaching $396.75M last quarter. TTM EBITDA of $245.91M and TTM operating income of $194.40M show growth is flowing through to the bottom line. TTM net income of $99.72M means revenue is converting into profit.
TTM Revenue
Reveals whether the core business is growing or shrinking
Quarterly Revenue
Highlights seasonal patterns and short-term momentum
TTM EBITDA
Shows if underlying operating profitability is improving
Quarterly EBITDA
Tracks near-term operating profitability trends
TTM Operating Income
Smoothed operating profit over the past four quarters
Quarterly Operating Income
Profit from core operations before financing costs
TTM Net Income
The bottom line — is the company making more money?
Quarterly Net Income
Short-term profit after all expenses and taxes
EPS
Earnings per share — profit attributable to each share
Shares Outstanding
Declining means buybacks benefit remaining holders